Griffith University, Brisbane, Australia.
Family Focused Healthcare Research Center (FaCe), Department of Clinical Research, University of Southern Denmark, J.B. Winsløws Vej 19.3, 5000, Odense C, Denmark.
Support Care Cancer. 2024 Oct 8;32(11):712. doi: 10.1007/s00520-024-08909-1.
This review aimed to synthesize the literature regarding health interventions delivered to adult cancer survivors and their families during posttreatment phase.
An integrative literature review was conducted that included quantitative and qualitative studies. The search was carried out in four databases using the same terms or MeSH terms and included data from January 2012 to February 2024. After quality assessment, data were extracted and synthesized. The protocol was registered in PROSPERO.
Among the seven studies included, two studies were randomized controlled trials, three were observational, and two utilized a qualitative approach. The studies originated from France, Australia, Canada, the UK, and the USA. In total, 704 participants were included, 294 were cancer survivors, 40 were non-cancer patients, 271 were family and caregivers, and 99 were healthcare professionals. The studies assessed survival durations after cancer treatment, ranging from 18 months to 6 years. The sparse interventions found across the studies used a multifaceted approach tailored to address various aspects of cancer survivorship and caregiver support.
This review provides insights into the complex landscape of posttreatment support requirements for cancer survivors and their family caregivers. This finding underscores the critical necessity for additional intervention research involving comprehensive, accessible, and supportive services that address the multifaceted dimensions of survivorship for the patient and family as a unit.
本综述旨在综合关于成人癌症幸存者及其家属在治疗后阶段接受的健康干预措施的文献。
进行了一项综合文献综述，包括定量和定性研究。使用相同的术语或 MeSH 术语在四个数据库中进行了搜索，数据时间范围为 2012 年 1 月至 2024 年 2 月。经过质量评估后，提取和综合了数据。该方案已在 PROSPERO 中注册。
纳入的 7 项研究中，有 2 项为随机对照试验，3 项为观察性研究，2 项采用定性方法。研究来源于法国、澳大利亚、加拿大、英国和美国。共有 704 名参与者，294 名是癌症幸存者，40 名是非癌症患者，271 名是家庭和照顾者，99 名是医疗保健专业人员。研究评估了癌症治疗后生存时间，从 18 个月到 6 年不等。研究中发现的干预措施很少，采用了多方面的方法，针对癌症幸存者和照顾者支持的各个方面进行了定制。
本综述提供了对癌症幸存者及其家庭照顾者治疗后支持需求的复杂情况的深入了解。这一发现强调了需要进行更多涉及全面、可及和支持性服务的干预研究的重要性，这些服务需要针对患者和家庭作为一个单位的生存多方面维度进行。
